New Therapeutic Target for Melanoma Identified

	Tweet

A protein called Mcl-1 plays a critical role in melanoma cell resistance to a form of apoptosis called anoikis, according to research published this week in Molecular Cancer Research.

The presence of Mcl-1 causes cell resistance to anoikis. This resistance to anoikis enables the melanoma cells to metastasize and survive at sites distant from the primary tumor, according to Andrew Aplin, Ph.D., an associate professor of Cancer Biology at Jefferson Medical College of Thomas Jefferson University, and a member of the Kimmel Cancer Center at Jefferson. The research was conducted at Albany Medical College in New York by Dr. Aplin and colleagues.

Mcl-1 is part of the Bcl-2 protein family, and is regulated by B-RAF proteins, which are mutated in approximately 60 percent of all human melanomas.

The Bcl-2 family includes several prosurvival proteins that are associated with the resistance of cancer cells to apoptosis, or cell death. Dr. Aplin and colleagues analyzed three candidate Bcl-2 proteins: Mcl-1, Bcl-2 and Bcl-XL.

“When we depleted Mcl-1 from the tumor cells, they were susceptible to cell death,” Dr. Aplin said. “Mcl-1 showed dramatic results compared to Bcl-2 and Bcl-XL, which was a surprise. Our findings show that targeting Mcl-1, which is upregulated in a majority of melanoma cells, could be a viable treatment strategy.”

Dr. Aplin said there are therapeutic agents in development to target this protein family, but most specifically target Bcl-2 and Bcl-XL. There is one agent in development by Gemin X Biotech that targets Mcl-1. This agent, called obatoclax, is currently in phase I/II trials.

Source: Thomas Jefferson University

RELATED STORIES:
High iron and cholesterol equals high cancer risk   Cancer that colonizes our bodies   Monoclonal Antibody Drugs for Cancer Treatment   Anti-cancer drugs based on platinum   Study quantifies racial disparities in cancer mortality rates between blacks and whites   Cancer survivors at higher risk of mental distress   U.S. cancer drugs shortage has doctors scrambling   Cancer gene therapy from camels   Gene Therapy Improves Survival and Quality of Life of Dogs with Cancer   Genome study shows what cancers have in common   Shorter radiation course okay for bone cancer pain   Blocking cell movement for cancer, MS treatment   Virtual Exams Detect Cancer Risks   Researchers Find Cancer News May Contribute To Confusion About Cancer   Europe varies widely in at-home cancer deaths   Cancer Patients Pain Can Be Helped By Psychosocial Interventions   Physics, Math Provide Clues to Unraveling Cancer   10 Ways to Reduce Cancer Risk   Antibody signal may redirect inflammation to fuel cancer   Breastfeeding – added protection for cancer survivors?   A Ray of Sunshine in the Fight Against Cancer   Study finds way to predict when cancer will spread

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]